Michigan Democratic U.S. Senate candidate Abdul El-Sayed stated that government interference in medical decisions regarding gender-affirming care is inappropriate, arguing that such choices should be made between patients, parents, and their physicians. El-Sayed, who has promoted his medical background during his campaign, made these remarks at a rally at Michigan State University.
El-Sayed emphasized that medical professionals, having undergone extensive education and training, are the experts best equipped to determine necessary treatment plans. "They are the experts that a patient wants to see when they seek care," he said. "And the decision about what healthcare is necessary ought to be held between a patient — and or their parents if they're under the age of 18 — and their doctor. That's it."
His comments come amid broader political discussions and governmental actions to restrict access to gender-affirming procedures for minors. The Justice Department has announced agreements with several hospitals to halt such procedures for children, following similar actions and policy shifts in other states.
El-Sayed, a proponent of Medicare for All, believes that while the government may cover healthcare costs, it should not dictate specific treatment protocols. "I don't think the government gets to have a say about what health care is provided in what circumstances and why," El-Sayed stated. He drew a parallel to the conservative-backed "Right to Try" legislation, which allows terminally ill patients access to experimental treatments, suggesting that this principle aligns with the idea that individuals and their providers should direct healthcare decisions.
"Because conservatives fought for a very long time for this legislation called 'Right to Try' legislation, which is the idea that the government couldn't tell you [that] you couldn't have a certain medication," El-Sayed explained. "So they agree that the decision about healthcare ought to be between the person and their provider. That's it. So let's use that standard, and keep to that standard, and make sure the government doesn't have the ability to tell you what you can or cannot do with your own life."
The efficacy and safety of gender-affirming treatments for minors remain subjects of debate and research. International health bodies, such as England's National Health Service, have placed restrictions on hormone treatments for adolescents, citing limited research. The World Professional Association for Transgender Health (WPATH), a leading organization in the field, is reportedly facing legal scrutiny regarding its guidelines and disclosures about the potential side effects of such treatments. Some research on the topic, including studies on the use of puberty blockers and cross-sex hormones, has been described as limited in scope.